December 28, 2017 / 6:50 AM / a year ago

BRIEF-China Pioneer Pharma Enters Agreement For Sale Of Ophthalmic Pharmaceutical Products

Dec 28 (Reuters) - China Pioneer Pharma Holdings Ltd :

* CO ‍ENTERED AGREEMENT WITH ALCON AND AFFILIATE BEIJING NOVARTIS PHARMACEUTICAL CO FOR SALE OF OPHTHALMIC PHARMACEUTICAL PRODUCTS

* PARTIES AGREE THAT ALCON & BEIJING NOVARTIS TO CONTINUE TO SUPPLY MINIMUM VALUE OF ALCON PRODUCTS TO CO FOR YEAR ENDING DEC 2018

* ‍ TOTAL VALUE OF ALCON PRODUCTS WHICH GROUP MAY SELL IN 2018 WILL BE NO LESS THAN RMB617 MILLION (NET OF TAX)​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below